Neurocrine Biosciences (NBIX) FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| FCF, bln rub | ? | 233.1 | 322.9 | 361.6 | 557.2 | 748.7 | 831.3 | ||
| Changes by years, y/y, % | +7% | +39% | +12% | +54% | +34% | +28.0% | |||
Neurocrine Biosciences. FCF, bln rub
Neurocrine Biosciences. FCF, changes, %
Neurocrine Biosciences. FCF, sum by quarters, bln rub
Neurocrine Biosciences (NBIX) FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| FCF, bln rub | ? | 54.1 | 89.5 | 214.3 | 390.8 | 136.7 | 831.3 | |
| Changes by years, y/y, % | -55% | +69% | +43% | +66% | +153% | |||
| Changes by quarters, q/q, % | -77% | +65% | +139% | +82% | -65% | |||